Peptides · Peptide comparison
Cerebrolysin vs Semax
Porcine brain-derived neuropeptide preparation containing bioactive peptide fragments of neurotrophic factors, used clinically in over 40 countries for stroke recovery, traumatic brain injury, and cognitive impairment
A brain-boosting peptide that supercharges your cognitive function by ramping up BDNF—the protein your neurons need to grow, connect, and stay sharp—all delivered through a simple nasal spray.
- Cognitive
- Cognitive
At a glance
Quick comparison
Efficacy
Benefit ratings
Stroke Recovery
Alzheimer's Support
Brain Injury Healing
Cognitive Enhancement
Neuroprotection
Mental Energy
Technical data
Compound specifications
Cerebrolysin
- Molecular formula
- Complex mixture — no single molecular formula (contains multiple peptide fragments and free amino acids derived from porcine brain proteins)
- Molecular weight
- Bioactive peptide components are all below 10 kDa (10,000 Da); the preparation contains a spectrum of peptide sizes
- Half-life
- Approximately 15-30 minutes (IV administration)
- Bioavailability
- ~85-100% (intramuscular injection)
- CAS number
- Not assigned (biological mixture)
Semax
- Molecular formula
- C37H51N9O10S
- Molecular weight
- 813.9 g/mol
- Half-life
- Several minutes to hours (intranasal effects persist longer)
- Bioavailability
- High via intranasal route (directly reaches brain)
- CAS number
- 80714-61-0
Protocols
Dosing compared
Cerebrolysin
Intravenous
- 10 mLOnce daily · 10-20 day course, repeated every 3-6 monthsA gentle starting dose given as a slow IV infusion (often diluted in saline). Used in dementia and recovery programs. [6][7]
- 20-30 mLOnce daily · 10-21 day course, repeated in cyclesThe common clinical dose. Trials in vascular dementia used 20 mL daily, and stroke trials used 30 mL daily (diluted to about 100 mL saline) infused over ~30 minutes. [6][7]
- 30-50 mLOnce daily · 10-21 days for stroke or severe brain injuryThe higher end used for acute stroke and severe traumatic brain injury, given as a diluted IV infusion under medical supervision. [7]
Intramuscular
- 5-10 mLOnce daily · Up to 10-20 days per courseFor smaller doses, Cerebrolysin can be given as an intramuscular injection (no more than ~5 mL per injection site). Often used for milder cases or maintenance between IV cycles. [7]
Semax
Intranasal
- 250-500 mcg/dayOnce or twice daily · 1-2 weeksCognitive/nootropic practice with the 0.1% solution; downstream BDNF/NGF effects persist 12-24 h so dosing is once to twice daily [1][2].
- 500-900 mcg/dayDivided 2-3 times daily · 3-4 weeksMid-range nootropic practice dose; upregulates hippocampal BDNF/TrkB in animal models [1][2][3].
Applications
Best suited for
Cerebrolysin
- Post-stroke neurorecovery and rehabilitation support
- Cerebrolysin is particularly well-suited for individuals focused on post-stroke neurorecovery and rehabilitation support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [2][13].
- Cognitive support in Alzheimer's disease and vascular dementia
- Cerebrolysin is particularly well-suited for individuals focused on cognitive support in alzheimer's disease and vascular dementia. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][6].
- Traumatic brain injury recovery and neuroprotection
- Cerebrolysin is particularly well-suited for individuals focused on traumatic brain injury recovery and neuroprotection. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [14].
- Age-related cognitive decline and mild cognitive impairment
- Cerebrolysin is particularly well-suited for individuals focused on age-related cognitive decline and mild cognitive impairment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
Semax
- Students and Knowledge Workers
- If your day revolves around learning, studying, or processing complex information, Semax can be a game-changer. It enhances memory consolidation and recall while improving your ability to focus for extended periods—perfect for exam prep or demanding projects [6][12].
- Those Seeking Mental Clarity
- Brain fog? Semax works by boosting BDNF—the protein that helps neurons communicate effectively. [1][2] Users often report feeling like the 'mental static' clears away, leaving sharper, more efficient thinking in its place.
- Neuroprotection Seekers
- Beyond immediate cognitive benefits, Semax offers protective effects for your brain cells. [9] It acts as an antioxidant (especially against copper toxicity) [4][8] and supports neuronal health—valuable for anyone concerned about long-term brain wellness.
- Recovery Support (Under Medical Supervision)
- In Russia, Semax is approved for helping stroke patients and those with traumatic brain injuries recover cognitive function. [6] While not FDA-approved for this use elsewhere, the research shows meaningful neuroprotective and neurorestorative properties [7][9].
Safety profile
Side effects
Cerebrolysin
Common
- Injection site reactions
- Headache
- Dizziness and vertigo
- Nausea and gastrointestinal discomfort
- Agitation or restlessness
- Fever
Uncommon
- Allergic reaction
Serious
- Severe hypersensitivity reaction
Semax
Common
- Nasal irritation
- Mild headache
- Increased alertness
Uncommon
- Temporary blood pressure increase
- Dizziness
Serious
- Allergic reaction
Research status
Safety & evidence
Cerebrolysin
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Cerebrolysin is an FDA-unregulated neuroprotective agent consisting of porcine brain-derived peptides and amino acids that has been used primarily in Eastern Europe and Asia. [8][12] Safety data is limited to observational clinical use and small open-label trials rather than rigorous randomized controlled trials with formal safety monitoring. As a complex mixture of undefined peptide fragments from animal sources, batch consistency and sterility cannot be guaranteed without pharmaceutical manufacturing standards. Potential allergic reactions to porcine proteins and transmissible spongiform encephalopathy (TSE) risks from animal-derived components have not been adequately ruled out.
Contraindications
- Known hypersensitivity to Cerebrolysin or porcine-derived products
- Severe renal impairment or renal failure
- Status epilepticus or uncontrolled epilepsy
- Pregnancy and breastfeeding — insufficient safety data
Semax
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Semax has been used clinically in Russia for over 25 years with an excellent safety profile. [7][12] It's approved there for treating stroke, cognitive impairment, and optic nerve diseases. [6] Studies consistently show minimal side effects, mostly limited to mild nasal irritation when using the spray form. [6][9] Unlike stimulants, Semax doesn't appear to cause tolerance, dependence, or withdrawal symptoms even with extended use.
Contraindications
- Pregnancy or planning to become pregnant
- Currently breastfeeding
- History of seizures or epilepsy
- Known allergy to ACTH-related peptides
- Uncontrolled hypertension
Decision guide
Which is right for you?
Cerebrolysin
Choose Cerebrolysin if…
- Post-stroke neurorecovery and rehabilitation support
- Cognitive support in Alzheimer's disease and vascular dementia
- Traumatic brain injury recovery and neuroprotection
- Age-related cognitive decline and mild cognitive impairment
Semax
Choose Semax if…
- Cognitive enhancement
- Memory improvement
- Focus and concentration
- Neuroprotection